Find Suplatast Tosilate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Suplatast tosylate, 94055-76-2, Ipd 1151t, Ipd-1151t, Suplatast (tosilate), Suplatasttosilate
Molecular Formula
C23H33NO7S2
Molecular Weight
499.6  g/mol
InChI Key
RYVJQEZJUFRANT-UHFFFAOYSA-N
FDA UNII
C9J89787U1

Suplatast Tosilate
1 2D Structure

Suplatast Tosilate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate
2.1.2 InChI
InChI=1S/C16H25NO4S.C7H8O3S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3;1-6-2-4-7(5-3-6)11(8,9)10/h5-8,14,18H,4,9-12H2,1-3H3;2-5H,1H3,(H,8,9,10)
2.1.3 InChI Key
RYVJQEZJUFRANT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOCC(COC1=CC=C(C=C1)NC(=O)CC[S+](C)C)O.CC1=CC=C(C=C1)S(=O)(=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
C9J89787U1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)ethyl)dimethylsulfonium P-toluenesulfonate

2. Ipd 1151t

3. Ipd-1151t

2.3.2 Depositor-Supplied Synonyms

1. Suplatast Tosylate

2. 94055-76-2

3. Ipd 1151t

4. Ipd-1151t

5. Suplatast (tosilate)

6. Suplatasttosilate

7. Suplatast Tosilate [inn]

8. 94055-76-2 (tosylate)

9. C9j89787u1

10. (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate

11. Dsstox_cid_25003

12. Dsstox_rid_80646

13. Dsstox_gsid_45003

14. [3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate

15. Sulfonium, (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethyl-, Salt With 4-methylbenzenesulfonic Acid (1:1)

16. Suplatastum Tosilas

17. Cas-94055-76-2

18. Ccris 6596

19. Tosilate De Suplatast

20. Tosilato De Suplatast

21. Suplatastum Tosilas [inn-latin]

22. Ncgc00181000-01

23. Tosilate De Suplatast [inn-french]

24. Tosilato De Suplatast [inn-spanish]

25. Unii-c9j89787u1

26. [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethylsulfonium 4-methylbenzenesulfonate

27. Mfcd00867604

28. Ym-672

29. Ipd (tn)

30. (+-)-(2-(4-(3-ethoxy-2-hydroxypropoxy)phenyl)carbamoyl)ethyldimethylsulfonium P-tosylate

31. Schembl29042

32. Mls006010745

33. Suplatast Tosilate (jan/inn)

34. Chembl115435

35. Suplatast Tosylate [mi]

36. Dtxsid9045003

37. Suplatast Tosilate [jan]

38. Hms3413p08

39. Hms3655l09

40. Hms3677p08

41. Suplatast Tosilate [mart.]

42. Amy40561

43. Bcp10310

44. Suplatast Tosilate [who-dd]

45. Tox21_112652

46. S2015

47. Suplatast Tosylate, >=98% (hplc)

48. Akos015900359

49. Tox21_112652_1

50. Ccg-269685

51. Cs-0574

52. Ks-1288

53. Ncgc00181000-02

54. (+-)-(2-((p-(3-ethoxy-2-hydroxypropoxy)phenyl)carbamoyl)ethyl)dimethylsulfonium P-toluenesulfonate

55. Hy-17002

56. Smr004701701

57. Ft-0650625

58. S0875

59. Sw219352-1

60. C77240

61. D01423

62. Q7644399

63. 2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyldimethylsulfonium P-toluenesulfonate

64. (3-(4-(3-ethoxy-2-hydroxypropoxy)phenylamino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 499.6 g/mol
Molecular Formula C23H33NO7S2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count10
Exact Mass499.16984474 g/mol
Monoisotopic Mass499.16984474 g/mol
Topological Polar Surface Area134 Ų
Heavy Atom Count33
Formal Charge0
Complexity500
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


Histamine Antagonists

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)


Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty